Freenome Reports Third Quarter 2026 Financial Results
– Third-quarter results reflect revenue of $183.5 million driven by the FDA approval of SimpleScreen™ CRC –
– Third-quarter results reflect revenue of $183.5 million driven by the FDA approval of SimpleScreen™ CRC –